Suggest an update

YC W26 · Active

Origin

AI and Data for Cancer Therapeutics

Class
Winter 2026
Status
Active
Industry
Healthcare
Location
San Francisco, CA, USA
Team size
8

Website

https://origin.bio/

About

We produce patient-derived cancer datasets for licensing to pharmaceutical and AI companies. Our data comprises matched spatial transcriptomics, H&E and clinical labels. We operate our own laboratory, where samples are processed. Samples are sourced from leading biobank / hospital networks. As R&D workflows increasingly rely on frontier AI systems, we believe there is critical need for real world datapoints so that findings translate in the clinic.